ctrl K

Advertisement

Revelation Biosciences Inc. (REVB)

NASDAQ: REVB · Real-Time Price · USD

3.00

0.08 (2.74%)

At close: Apr 29, 2025, 11:50 AM

Revelation Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	25.05K	40.01K	69.17K	n/a	n/a
Gross Profit	n/a	-25.05K	-40.01K	-69.17K	n/a	n/a
Operating Income	-7.98B	-8.66M	-10.86M	-11.95M	-145.49K	-3.64K
Interest Income	n/a	n/a	n/a	n/a	10.91K	n/a
Pretax Income	-15.04B	-120.25K	-10.83M	-11.99M	-1.63M	-3.64K
Net Income	-15.04B	-120.25K	-10.79M	-11.99M	-1.63M	-3.64K
Selling & General & Admin	4.43B	4.51M	5.49M	5.04M	145.49K	3.64K
Research & Development	3.55B	4.15M	5.38M	6.91M	2.56M	n/a
Other Expenses	n/a	n/a	34.96K	-36.35K	n/a	n/a
Operating Expenses	7.98B	8.66M	10.86M	11.95M	145.49K	3.64K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	144.26K	n/a
Cost & Expenses	n/a	8.66M	10.86M	11.95M	145.49K	3.64K
Income Tax Expense	n/a	n/a	-34.96K	-219.78K	-3.8K	-171.86K
Shares Outstanding (Basic)	1.72M	228K	17.97K	9.4K	8.66K	8.66K
Shares Outstanding (Diluted)	1.72M	228.64K	17.97K	9.4K	8.66K	8.66K
EPS (Basic)	-8.77K	-0.53	-600.77	-1.28K	-188.18	-0.42
EPS (Diluted)	-8.77K	-0.53	-600.77	-1.28K	-188.18	-0.42
EBITDA	-7.98B	-95.21K	-10.84M	-11.93M	-145.49K	-3.64K
EBIT	n/a	-120.26K	-10.83M	-11.99M	-1.63M	-3.64K
Depreciation & Amortization	n/a	25.05K	40.01K	69.17K	3.8M	171.86K